Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
CDC.gov. Multistate Outbreak of Shiga Toxin-producing Escherichia coli O145 Infections.
CDC.gov. Notice to Health Care Providers - Shiga Toxin-producing E. coli O104 (STEC O104:H4) Infections in U.S. Travelers Returning from Germany.
CDC.gov. Escherichia coli O157:H7.
CDC.gov.. Recommendations for Diagnosis of Shiga Toxin--Producing Escherichia coli Infections by Clinical Laboratories.
MedscapeReference.com. Hemolytic Uremic Syndrome.
Kumarasamy, K.K. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. The Lancet, published online Aug. 11, 2010. (NDM)
Pitout, J.D.D. The latest threat in the war on antimicrobial resistance. The Lancet, published online Aug. 11, 2010.
Textookofbacteriology.net. Pathogenic E. coli.
U.S. Food and Drug Administration. BBB - Escherichia coli O157:H7 (EHEC).